SCHEMBL2386444

SCHEMBL2386444

COC(=O)Cc1cc(Br)cc(C(C)C)c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSP90AB1 P08238 1/20 0.50
CYP4F2 P78329 1/20 0.40
CYP4A11 Q02928 1/20 0.40
ALDH1A1 P00352 3/20 0.40
GAA P10253 1/20 0.40
GFER P55789 1/20 0.40
SLC7A5 Q01650 1/20 0.38
RAB9A P51151 3/20 0.38
SMN1; SMN2 Q16637 3/20 0.38
NPC1 O15118 2/20 0.38
TP53 P04637 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
KMT2A Q03164 2/20 0.37
KDM4E B2RXH2 1/20 0.37
MAPT P10636 2/20 0.36
LMNA P02545 1/20 0.35
HPGD P15428 2/20 0.35
TSHR P16473 2/20 0.35
THRA P10827 1/20 0.33
THRB P10828 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8257613 0.84 HSP90AB1 (0.62) HSP90AB1CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL8360725 0.84 HSP90AB1 (0.62) HSP90AB1CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL27725733 0.78 HSP90AB1 (0.76) HSP90AB1CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL2912231 0.78 HSP90AB1 (0.55) HSP90AB1CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL138004 0.77 HSP90AB1 (0.53) HSP90AB1CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL4213163 0.77 HSP90AB1 (0.53) HSP90AB1CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL18554389 0.77 HSP90AB1 (0.53) HSP90AB1CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL1559919 0.77 HSP90AB1 (0.53) HSP90AB1CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL8186958 0.75 SLC7A5 (0.56) HSP90AB1CYP4F2CYP4A11ALDH1A1GAA
SCHEMBL10141612 0.74 CYP11B1 (0.49) HSP90AB1CYP4F2CYP4A11ALDH1A1GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8013001-B2 Modulators of LXR EXELIXIS, INC. (US) 2011-09-06 US disclosed
US-20100056582-A1 Modulators of LXR X-CEPTOR THERAPEUTICS, INC. (US) 2010-03-04 US disclosed
US-7482366-B2 Modulators of LXR X-CEPTOR THERAPEUTICS, INC. (US) 2009-01-27 US disclosed
US-20080119488-A1 Modulators Of Nuclear Receptors EXELIXIS, INC. (US) 2008-05-22 US disclosed
EP-1773337-A2 MODULATORS OF NUCLEAR RECEPTORS Exelixis, Inc. (US) 2007-04-18 EP disclosed
WO-2006025979-A9 MODULATORS OF NUCLEAR RECEPTORS EXELIXIS INC (US) 2006-04-20 WO disclosed
WO-2006025979-A2 MODULATORS OF NUCLEAR RECEPTORS EXELIXIS, INC. (US) 2006-03-09 WO disclosed
US-20050080111-A1 Modulators of LXR X-CEPTOR THERAPEUTICS, INC. (US) 2005-04-14 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080119488-A1 Modulators Of Nuclear Receptors NR1H2, NR0B1, NR1H3 HSP90AB1 2681/4885CYP4F2 135/4885CYP4A11 40/4885
US-20050080111-A1 Modulators of LXR NR1H2, NR1H3, NR1H4 HSP90AB1 2159/4885CYP4F2 279/4885CYP4A11 42/4885
US-20100056582-A1 Modulators of LXR NR1H2, NR1H3, NR1H4 HSP90AB1 2159/4885CYP4F2 279/4885CYP4A11 42/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.